X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (20) 20
index medicus (20) 20
female (18) 18
male (17) 17
middle aged (15) 15
aged (11) 11
medicine, general & internal (11) 11
abridged index medicus (9) 9
adult (9) 9
diabetes (9) 9
diabetes mellitus, type 2 - drug therapy (9) 9
insulin (9) 9
clinical trials (7) 7
endocrinology & metabolism (7) 7
treatment outcome (7) 7
blood glucose - analysis (6) 6
diabetes mellitus, type 2 - blood (6) 6
dosage and administration (6) 6
drug administration schedule (6) 6
therapy (6) 6
type 2 diabetes (6) 6
blood glucose - drug effects (5) 5
cardiovascular disease (5) 5
care and treatment (5) 5
glucose (5) 5
glycated hemoglobin a - analysis (5) 5
glycemic control (5) 5
hypoglycemic agents - administration & dosage (5) 5
hypoglycemic agents - therapeutic use (5) 5
mortality (5) 5
aged, 80 and over (4) 4
association (4) 4
blood glucose - metabolism (4) 4
cardiovascular diseases (4) 4
cerebral infarction (4) 4
diabetes mellitus (4) 4
double-blind method (4) 4
drug therapy (4) 4
endocrine system diseases (4) 4
follow-up studies (4) 4
heart diseases (4) 4
hyperglycemia (4) 4
management (4) 4
myocardial infarction (4) 4
patients (4) 4
sulfonylurea (4) 4
cardiovascular diseases - mortality (3) 3
cardiovascular diseases - prevention & control (3) 3
comparative analysis (3) 3
critically-ill patients (3) 3
cross-sectional studies (3) 3
death (3) 3
diabetes mellitus, type 2 - complications (3) 3
diabetes mellitus, type 2 - diagnosis (3) 3
dose-response relationship, drug (3) 3
drug therapy, combination (3) 3
hemoglobin (3) 3
hospitalization (3) 3
hospitalization - statistics & numerical data (3) 3
hyperglycemia - chemically induced (3) 3
hypoglycemic agents - adverse effects (3) 3
insulin - administration & dosage (3) 3
insulin - therapeutic use (3) 3
insulin glargine (3) 3
mellitus (3) 3
prospective studies (3) 3
research (3) 3
safety (3) 3
statistics, epidemiology and research design (3) 3
stroke (3) 3
studies (3) 3
time factors (3) 3
trial (3) 3
1506 (2) 2
1843 (2) 2
administration, oral (2) 2
algorithms (2) 2
analysis (2) 2
angina (2) 2
article (2) 2
automation (2) 2
basal insulin (2) 2
benzhydryl compounds - therapeutic use (2) 2
blood pressure (2) 2
blood sugar (2) 2
chemistry, multidisciplinary (2) 2
chemistry, physical (2) 2
diabetes and endocrinology (2) 2
diabetes therapy (2) 2
diagnostic techniques and procedures (2) 2
end-stage renal disease (2) 2
exendin-4 (2) 2
glomerular filtration rate (2) 2
glucagon-like peptide 1 - agonists (2) 2
glucose control (2) 2
glucose tolerance test (2) 2
glucosides - therapeutic use (2) 2
glycated hemoglobin (2) 2
glycated hemoglobin a - metabolism (2) 2
heart attacks (2) 2
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Trinity College (John W Graham) - Wycliffe Storage (2) 2
Knox College (Caven) - Stacks (1) 1
Knox College (Caven) - Storage (1) 1
St. Michael's College (John M. Kelly) - 3rd Floor (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
Victoria University CRRS - Library use only (1) 1
Victoria University Emmanuel College - Storage (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
by Heerspink, Hiddo J L and Parving, Hans-Henrik and Andress, Dennis L and Bakris, George and Correa-Rotter, Ricardo and Hou, Fan-Fan and Hou, Fanfan and Kitzman, Dalane W and Kohan, Donald and Makino, Shinya and Makino, Hirofumi and McMurray, John J V and Melnick, Joel Z and Miller, Michael G and Miller, Alan and Miller, Steven and Pergola, Pablo E and Pergola, Pablo and Perkovic, Vlado and Tobe, Sheldon and Yi, Joo Hark and Yi, Tingting and Wigderson, Melissa and de Zeeuw, Dick and Elbert, Alicia and Vallejos, Augusto and Alvarisqueta, Andres and Maffei, Laura and Juncos, Luis and de Arteaga, Javier and Greloni, Gustavo and Farias, Eduardo and Zucchini, Alfredo and Vogel, Daniel and Cusumano, Ana and Santos, Juan and Fraenkel, Margaret and Gallagher, Martin and Davis, Tim and Acharya, Shamasunder and Cooke, Duncan and Suranyi, Michael and Roger, Simon and Toussaint, Nigel and Pollock, Carol and Chan, Doris and Stranks, Stephen and MacIsaac, Richard and Endre, Zoltan and Schmidt, Alice and Schmidt, Rebecca and Prager, Rudolf and Mayer, Gert and Warling, Xavier and Jadoul, Michel and Hougardy, Jean and Vercammen, Chris and Van Vlem, Bruno and Gillard, Pieter and Costa e Forti, Adriana and Borges, Joao Lindolfo and Santos Canani, Luis and Eliaschewitz, Freddy and Leite, Silmara and Fraige Filho, Fadlo and Paschoalin, Raphael and Moura Neto, Jose Andrade and Deboni, Luciane and de Lourdes Noronha, Irene and Cercato, Cintia and Prompt, Carlos Alberto and Zanella, Maria and Rassi, Nelson and D'Avila, Domingos and Milagres, Rosangela and Felicio, Joao and Pecoits Filho, Roberto and Riella, Miguel Carlos and Salles, Joao and Keitel, Elizete and Draibe, Sergio and Amodeo, Celso and Youmbissi, Joseph and Roy, Louise and Cournoyer, Serge and Jolly, Shivinder and Pichette, Vincent and Nesrallah, Gihad and Bajaj, Harpreet Singh and Khandwala, Hasnain and Aronson, Ronnie and Goluch, Richard and Tam, Paul and Rabbat, Christian and Bailey, Gordon and Chow, Stephen and Castillo, Alvaro and Danin Vargas, Alfredo and Gonzalez, Fernando and Munoz, Rodrigo and ... and SONAR Comm Investigators and SONAR Committees and Investigators
The Lancet, ISSN 0140-6736, 05/2019, Volume 393, Issue 10184, pp. 1937 - 1947
Short-term treatment for people with type 2 diabetes using a low dose of the selective endothelin A receptor antagonist atrasentan reduces albuminuria without... 
MEDICINE, GENERAL & INTERNAL | INHIBITION | ENDOTHELIN | ALBUMINURIA | NEPHROPATHY | Humans | Middle Aged | Male | Diabetic Nephropathies - blood | Serum Albumin, Human - urine | Young Adult | Aged, 80 and over | Adult | Female | Diabetic Nephropathies - prevention & control | Endothelin A Receptor Antagonists - therapeutic use | Diabetic Nephropathies - urine | Glomerular Filtration Rate | Double-Blind Method | Endothelin A Receptor Antagonists - administration & dosage | Administration, Oral | Treatment Outcome | Creatinine - urine | Renal Insufficiency, Chronic - blood | Renal Insufficiency, Chronic - prevention & control | Atrasentan - therapeutic use | Creatinine - blood | Aged | Atrasentan - administration & dosage | Diabetes Mellitus, Type 2 - drug therapy | Renal Insufficiency, Chronic - urine | Short term | Enrichment | End-stage renal disease | Renal function | Endothelin | Heart attacks | Peptides | Clinical trials | Cardiovascular disease | Transplantation | Retention | Randomization | Renin | Motivation | Hemoglobin | Blood pressure | Safety | Diabetes mellitus (non-insulin dependent) | Heart diseases | Drug dosages | Heart failure | Urine | Creatinine | Enzymes | Kidneys | Epidermal growth factor receptors | Anemia | Diabetes mellitus | Health risks | Patients | Disease control | Glomerular filtration rate | Sodium | Angiotensin | Renal failure | Dialysis | Kidney diseases | Diabetes | Surface area | Potassium | Kidney transplantation | Long-term effects | Index Medicus | Abridged Index Medicus
Journal Article
Diabetes Care, ISSN 0149-5992, 2012, Volume 35, Issue 4, pp. 683 - 689
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2019, Volume 380, Issue 4, pp. 347 - 357
In a randomized trial of patients with type 2 diabetes, treatment with dapagliflozin, an SGLT2 inhibitor that promotes glucosuria, did not result in a higher... 
2013 ACCF/AHA GUIDELINE | MEDICINE, GENERAL & INTERNAL | SELECTIVE SGLT2 INHIBITOR | MANAGEMENT | HEART-FAILURE OUTCOMES | DISEASE | AMERICAN-COLLEGE | ASSOCIATION TASK-FORCE | KIDNEY | EMPAGLIFLOZIN | SOCIETY | Cardiovascular Diseases - etiology | Sodium-Glucose Transporter 2 Inhibitors - therapeutic use | Sodium-Glucose Transporter 2 Inhibitors - adverse effects | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Hospitalization - statistics & numerical data | Male | Benzhydryl Compounds - adverse effects | Cardiovascular Diseases - mortality | Female | Glucosides - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Benzhydryl Compounds - therapeutic use | Heart Failure - epidemiology | Diabetes Mellitus, Type 2 - complications | Glucosides - adverse effects | Type 2 diabetes | Safety and security measures | Dapagliflozin | Dosage and administration | Drug therapy | Cardiovascular diseases | Risk factors | Heart failure | Myocardial infarction | Cerebral infarction | End-stage renal disease | Heart attacks | Mortality | Diabetes mellitus | Cardiovascular disease | FDA approval | Patients | Glomerular filtration rate | Heart rate | Ischemia | Sodium | Arteriosclerosis | Ketoacidosis | Death | Diabetes | Kidney diseases | Safety | Diabetes mellitus (non-insulin dependent) | Heart diseases | Index Medicus | Abridged Index Medicus
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 04/2017, Volume 19, Issue 4, pp. 571 - 578
Journal Article